03 Mar Oculis Appoints Marcia de Souza Lima, M.D., as Chief Medical Officer Posted at 14:00h in Non classé 1 Like ... Read More
10 Fév Phase 2 Study Results of OCS-01: An Effective Topical Therapeutic for DME Posted at 14:50h in Non classé 1 Like ... Read More
22 Jan Oculis Announces Upcoming Presentation of Phase 2 Data of OCS-01 in DME Posted at 12:20h in Non classé 0 Likes ... Read More
07 Oct Oculis Announces Dosing of First Patient in Randomized Phase 2b (SKYGGN) Trial Posted at 14:30h in Non classé 0 Likes ... Read More
17 Sep Oculis Announces Appointment of Leading Specialists to Scientific Advisory Board Posted at 14:45h in Non classé 0 Likes ... Read More
16 Mai Why a pharma investor quit his day job to follow a vision (Guest interview) Posted at 17:30h in Non classé 0 Likes ... Read More
04 Jan Oculis Expands Portfolio with a Novel Phase II-stage Anti-TNF alpha Antibody Fragment Posted at 16:24h in Non classé 1 Like ... Read More
04 Jan Oculis Raises CHF15.5 million in an Extension of its Series B Financing Round Posted at 15:40h in Non classé 1 Like ... Read More
20 Nov Oculis Strengthens its Global Clinical and Business Development Capabilities Posted at 15:50h in Non classé 1 Like ... Read More
25 Sep Oculis appoints Pravin U. Dugel, M.D. as Chairman of its Scientific Advisory Board Posted at 16:09h in Non classé 1 Like ... Read More
